Cell-laden alginate hydrogels for the treatment of diabetes

  • Lukin Izeia
  • , Tatiane Eufrasio-da-Silva
  • , Alireza Dolatshahi-Pirouz
  • , Serge Ostrovidov
  • , Giovanna Paolone
  • , Nicholas A. Peppas
  • , Paul De Vos
  • , Dwaine Emerich
  • , Gorka Orive

Research output: Contribution to journal(Systematic) Review articlepeer-review

Abstract

Introduction Diabetes mellitus is an ever-increasing medical condition that currently suffers 1 of 11 adults who may have lifelong commitment with insulin injections. Cell-laden hydrogels releasing insulin may provide the ultimate means of correcting diabetes. Here, we provide insights of this cell-based approach including latest preclinical and clinical progress both from academia and industry. Area covered The present article focuses on reviewing latest advances in cell-laden hydrogels both from the technological and biological perspective. The most relevant clinical results including clinical trials are also discussed. Expert opinion Current progress in technological issues (stem cells, devices, biomaterials) have contributed cell encapsulation science to have a very relevant progress in the field of diabetes treatment.
Original languageEnglish
Pages (from-to)1113-1118
Number of pages6
JournalExpert Opinion on Drug Delivery
Volume17
Issue number8
DOIs
Publication statusPublished - 2 Aug 2020
Externally publishedYes

Keywords

  • Diabetes mellitus
  • Alginate
  • Cell encapsulation
  • Cell-laden hydrogels
  • Drug delivery

Fingerprint

Dive into the research topics of 'Cell-laden alginate hydrogels for the treatment of diabetes'. Together they form a unique fingerprint.

Cite this